GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 323 filers reported holding GLOBUS MED INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,994,292 | -75.2% | 29,118 | -80.6% | 0.04% | -75.4% |
| Q1 2024 | $8,056,943 | +40.4% | 150,204 | +39.5% | 0.17% | -63.5% |
| Q4 2023 | $5,737,308 | +3.8% | 107,662 | -3.3% | 0.46% | -3.6% |
| Q3 2023 | $5,529,074 | +3.8% | 111,361 | +24.5% | 0.47% | +9.0% |
| Q2 2023 | $5,326,329 | +7.0% | 89,458 | +1.8% | 0.44% | -2.5% |
| Q1 2023 | $4,976,390 | +1500.1% | 87,860 | +2061.9% | 0.45% | +1927.3% |
| Q3 2021 | $311,000 | -1.3% | 4,064 | 0.0% | 0.02% | -4.3% |
| Q2 2021 | $315,000 | +18.9% | 4,064 | -5.6% | 0.02% | +15.0% |
| Q1 2021 | $265,000 | -22.7% | 4,305 | -18.1% | 0.02% | -31.0% |
| Q4 2020 | $343,000 | +25.2% | 5,255 | -4.9% | 0.03% | +11.5% |
| Q3 2020 | $274,000 | -91.0% | 5,525 | -91.4% | 0.03% | -91.9% |
| Q2 2020 | $3,057,000 | +10.1% | 64,085 | -1.9% | 0.32% | -5.6% |
| Q1 2020 | $2,777,000 | – | 65,301 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 327,723 | $13,863,000 | 7.09% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 944,700 | $39,960,000 | 3.64% |
| Godshalk Welsh Capital Management, Inc. | 85,108 | $3,600,000 | 3.33% |
| NUANCE INVESTMENTS, LLC | 1,316,057 | $55,669,000 | 2.36% |
| Global Alpha Capital Management Ltd. | 264,350 | $11,182,000 | 1.94% |
| BROADVIEW ADVISORS LLC | 147,275 | $6,230,000 | 1.92% |
| Van Berkom & Associates Inc. | 1,476,695 | $62,464,000 | 1.81% |
| Pembroke Management, LTD | 319,037 | $13,495,000 | 1.42% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $8,460,000 | 1.28% |
| OAK RIDGE INVESTMENTS LLC | 408,731 | $17,289,000 | 1.20% |